ZIEXTENZO Trademark

Trademark Overview

On Thursday, October 8, 2015, a trademark application was filed for ZIEXTENZO with the United States Patent and Trademark Office. The USPTO has given the ZIEXTENZO trademark a serial number of 86781675. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2019. This trademark is owned by Novartis AG. The ZIEXTENZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and related symptoms
ziextenzo

General Information

Serial Number86781675
Word MarkZIEXTENZO
Filing DateThursday, October 8, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer and related symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 14, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, June 3, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 3, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, November 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 8, 2018EXTENSION 5 GRANTED
Thursday, November 1, 2018EXTENSION 5 FILED
Thursday, November 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2018TEAS EXTENSION RECEIVED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 25, 2018EXTENSION 4 GRANTED
Wednesday, April 25, 2018EXTENSION 4 FILED
Wednesday, April 25, 2018TEAS EXTENSION RECEIVED
Thursday, November 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2017EXTENSION 3 GRANTED
Tuesday, October 31, 2017EXTENSION 3 FILED
Tuesday, October 31, 2017TEAS EXTENSION RECEIVED
Thursday, April 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 25, 2017EXTENSION 2 GRANTED
Tuesday, April 25, 2017EXTENSION 2 FILED
Tuesday, April 25, 2017TEAS EXTENSION RECEIVED
Wednesday, November 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2016EXTENSION 1 GRANTED
Monday, October 31, 2016EXTENSION 1 FILED
Monday, October 31, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016ASSIGNED TO EXAMINER
Wednesday, October 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 12, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

ziextenzo related symptoms cancer treatment preparations pharmaceutical